KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cerence (CRNC) Total Liabilities (2018 - 2025)

Cerence's Total Liabilities history spans 8 years, with the latest figure at $451.6 million for Q4 2025.

  • For Q4 2025, Total Liabilities fell 9.1% year-over-year to $451.6 million; the TTM value through Dec 2025 reached $451.6 million, down 9.1%, while the annual FY2025 figure was $479.9 million, 14.49% down from the prior year.
  • Total Liabilities reached $451.6 million in Q4 2025 per CRNC's latest filing, down from $479.9 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $687.2 million in Q2 2021 to a low of $451.6 million in Q4 2025.
  • Average Total Liabilities over 5 years is $580.0 million, with a median of $604.1 million recorded in 2022.
  • Peak YoY movement for Total Liabilities: dropped 0.47% in 2023, then dropped 16.35% in 2024.
  • A 5-year view of Total Liabilities shows it stood at $642.9 million in 2021, then fell by 2.25% to $628.4 million in 2022, then decreased by 15.06% to $533.8 million in 2023, then dropped by 6.92% to $496.8 million in 2024, then dropped by 9.1% to $451.6 million in 2025.
  • Per Business Quant, the three most recent readings for CRNC's Total Liabilities are $451.6 million (Q4 2025), $479.9 million (Q3 2025), and $481.1 million (Q2 2025).